img

Global Nucleic Acid-based Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends

Publisher : MRA | Format : PDF

Global Nucleic Acid-based Drugs Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Nucleic Acid-based Drugs Market
The global Nucleic Acid-based Drugs market is projected to grow from US$ million in 2023 to US$ million by 2033, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Nucleic Acid-based Drugs is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The China market for Nucleic Acid-based Drugs is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The Europe market for Nucleic Acid-based Drugs is estimated to increase from $ million in 2023 to reach $ million by 2033, at a CAGR of % during the forecast period of 2023 through 2033.
The global key companies of Nucleic Acid-based Drugs include Ionis Pharmaceuticals, Sarepta Therapeutics, Nippon Shinyaku, BioNTech, Moderna Therapeutics, CureVac, Alnylam Pharmaceuticals, Regulus Therapeutics and Miragen Therapeutics, etc. in 2023, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Nucleic Acid-based Drugs market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2023, estimates for 2023, and projections of CAGR through 2033.
This report researches the key producers of Nucleic Acid-based Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Nucleic Acid-based Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nucleic Acid-based Drugs revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Nucleic Acid-based Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2033. Evaluation and forecast the market size for Nucleic Acid-based Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Ionis Pharmaceuticals, Sarepta Therapeutics, Nippon Shinyaku, BioNTech, Moderna Therapeutics, CureVac, Alnylam Pharmaceuticals, Regulus Therapeutics and Miragen Therapeutics, etc.



By Company


Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
BioNTech
Moderna Therapeutics
CureVac
Alnylam Pharmaceuticals
Regulus Therapeutics
Miragen Therapeutics
Mina Therapeutics
NeXstar Pharmaceuticals
Segment by Type
ASO
mRNA
siRNA
miRNA
saRNA
Aptamer

Segment by Application


Genetic Disease
Cancer
Cardiovascular Diseases
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Nucleic Acid-based Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Nucleic Acid-based Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nucleic Acid-based Drugs revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid-based Drugs Market Size Growth Rate by Type, 2018 VS 2023 VS 2033
1.2.2 ASO
1.2.3 mRNA
1.2.4 siRNA
1.2.5 miRNA
1.2.6 saRNA
1.2.7 Aptamer
1.3 Market by Application
1.3.1 Global Nucleic Acid-based Drugs Market Size Growth Rate by Application, 2018 VS 2023 VS 2033
1.3.2 Genetic Disease
1.3.3 Cancer
1.3.4 Cardiovascular Diseases
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid-based Drugs Market Perspective (2018-2033)
2.2 Global Nucleic Acid-based Drugs Growth Trends by Region
2.2.1 Nucleic Acid-based Drugs Market Size by Region: 2018 VS 2023 VS 2033
2.2.2 Nucleic Acid-based Drugs Historic Market Size by Region (2018-2023)
2.2.3 Nucleic Acid-based Drugs Forecasted Market Size by Region (2024-2033)
2.3 Nucleic Acid-based Drugs Market Dynamics
2.3.1 Nucleic Acid-based Drugs Industry Trends
2.3.2 Nucleic Acid-based Drugs Market Drivers
2.3.3 Nucleic Acid-based Drugs Market Challenges
2.3.4 Nucleic Acid-based Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Nucleic Acid-based Drugs by Players
3.1.1 Global Nucleic Acid-based Drugs Revenue by Players (2018-2023)
3.1.2 Global Nucleic Acid-based Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Nucleic Acid-based Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Nucleic Acid-based Drugs, Ranking by Revenue, 2021 VS 2023 VS 2023
3.4 Global Nucleic Acid-based Drugs Market Concentration Ratio
3.4.1 Global Nucleic Acid-based Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid-based Drugs Revenue in 2023
3.5 Global Key Players of Nucleic Acid-based Drugs Head office and Area Served
3.6 Global Key Players of Nucleic Acid-based Drugs, Product and Application
3.7 Global Key Players of Nucleic Acid-based Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid-based Drugs Breakdown Data by Type
4.1 Global Nucleic Acid-based Drugs Historic Market Size by Type (2018-2023)
4.2 Global Nucleic Acid-based Drugs Forecasted Market Size by Type (2024-2033)
5 Nucleic Acid-based Drugs Breakdown Data by Application
5.1 Global Nucleic Acid-based Drugs Historic Market Size by Application (2018-2023)
5.2 Global Nucleic Acid-based Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Nucleic Acid-based Drugs Market Size (2018-2033)
6.2 North America Nucleic Acid-based Drugs Market Size by Type
6.2.1 North America Nucleic Acid-based Drugs Market Size by Type (2018-2023)
6.2.2 North America Nucleic Acid-based Drugs Market Size by Type (2024-2033)
6.2.3 North America Nucleic Acid-based Drugs Market Share by Type (2018-2033)
6.3 North America Nucleic Acid-based Drugs Market Size by Application
6.3.1 North America Nucleic Acid-based Drugs Market Size by Application (2018-2023)
6.3.2 North America Nucleic Acid-based Drugs Market Size by Application (2024-2033)
6.3.3 North America Nucleic Acid-based Drugs Market Share by Application (2018-2033)
6.4 North America Nucleic Acid-based Drugs Market Size by Country
6.4.1 North America Nucleic Acid-based Drugs Market Size by Country: 2018 VS 2023 VS 2033
6.4.2 North America Nucleic Acid-based Drugs Market Size by Country (2018-2023)
6.4.3 North America Nucleic Acid-based Drugs Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Nucleic Acid-based Drugs Market Size (2018-2033)
7.2 Europe Nucleic Acid-based Drugs Market Size by Type
7.2.1 Europe Nucleic Acid-based Drugs Market Size by Type (2018-2023)
7.2.2 Europe Nucleic Acid-based Drugs Market Size by Type (2024-2033)
7.2.3 Europe Nucleic Acid-based Drugs Market Share by Type (2018-2033)
7.3 Europe Nucleic Acid-based Drugs Market Size by Application
7.3.1 Europe Nucleic Acid-based Drugs Market Size by Application (2018-2023)
7.3.2 Europe Nucleic Acid-based Drugs Market Size by Application (2024-2033)
7.3.3 Europe Nucleic Acid-based Drugs Market Share by Application (2018-2033)
7.4 Europe Nucleic Acid-based Drugs Market Size by Country
7.4.1 Europe Nucleic Acid-based Drugs Market Size by Country: 2018 VS 2023 VS 2033
7.4.2 Europe Nucleic Acid-based Drugs Market Size by Country (2018-2023)
7.4.3 Europe Nucleic Acid-based Drugs Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Nucleic Acid-based Drugs Market Size (2018-2033)
8.2 China Nucleic Acid-based Drugs Market Size by Type
8.2.1 China Nucleic Acid-based Drugs Market Size by Type (2018-2023)
8.2.2 China Nucleic Acid-based Drugs Market Size by Type (2024-2033)
8.2.3 China Nucleic Acid-based Drugs Market Share by Type (2018-2033)
8.3 China Nucleic Acid-based Drugs Market Size by Application
8.3.1 China Nucleic Acid-based Drugs Market Size by Application (2018-2023)
8.3.2 China Nucleic Acid-based Drugs Market Size by Application (2024-2033)
8.3.3 China Nucleic Acid-based Drugs Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Nucleic Acid-based Drugs Market Size (2018-2033)
9.2 Asia Nucleic Acid-based Drugs Market Size by Type
9.2.1 Asia Nucleic Acid-based Drugs Market Size by Type (2018-2023)
9.2.2 Asia Nucleic Acid-based Drugs Market Size by Type (2024-2033)
9.2.3 Asia Nucleic Acid-based Drugs Market Share by Type (2018-2033)
9.3 Asia Nucleic Acid-based Drugs Market Size by Application
9.3.1 Asia Nucleic Acid-based Drugs Market Size by Application (2018-2023)
9.3.2 Asia Nucleic Acid-based Drugs Market Size by Application (2024-2033)
9.3.3 Asia Nucleic Acid-based Drugs Market Share by Application (2018-2033)
9.4 Asia Nucleic Acid-based Drugs Market Size by Region
9.4.1 Asia Nucleic Acid-based Drugs Market Size by Region: 2018 VS 2023 VS 2033
9.4.2 Asia Nucleic Acid-based Drugs Market Size by Region (2018-2023)
9.4.3 Asia Nucleic Acid-based Drugs Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Country: 2018 VS 2023 VS 2033
10.4.2 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Ionis Pharmaceuticals
11.1.1 Ionis Pharmaceuticals Company Details
11.1.2 Ionis Pharmaceuticals Business Overview
11.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Introduction
11.1.4 Ionis Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.1.5 Ionis Pharmaceuticals Recent Developments
11.2 Sarepta Therapeutics
11.2.1 Sarepta Therapeutics Company Details
11.2.2 Sarepta Therapeutics Business Overview
11.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Introduction
11.2.4 Sarepta Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.2.5 Sarepta Therapeutics Recent Developments
11.3 Nippon Shinyaku
11.3.1 Nippon Shinyaku Company Details
11.3.2 Nippon Shinyaku Business Overview
11.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Introduction
11.3.4 Nippon Shinyaku Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.3.5 Nippon Shinyaku Recent Developments
11.4 BioNTech
11.4.1 BioNTech Company Details
11.4.2 BioNTech Business Overview
11.4.3 BioNTech Nucleic Acid-based Drugs Introduction
11.4.4 BioNTech Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.4.5 BioNTech Recent Developments
11.5 Moderna Therapeutics
11.5.1 Moderna Therapeutics Company Details
11.5.2 Moderna Therapeutics Business Overview
11.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Introduction
11.5.4 Moderna Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.5.5 Moderna Therapeutics Recent Developments
11.6 CureVac
11.6.1 CureVac Company Details
11.6.2 CureVac Business Overview
11.6.3 CureVac Nucleic Acid-based Drugs Introduction
11.6.4 CureVac Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.6.5 CureVac Recent Developments
11.7 Alnylam Pharmaceuticals
11.7.1 Alnylam Pharmaceuticals Company Details
11.7.2 Alnylam Pharmaceuticals Business Overview
11.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Introduction
11.7.4 Alnylam Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.7.5 Alnylam Pharmaceuticals Recent Developments
11.8 Regulus Therapeutics
11.8.1 Regulus Therapeutics Company Details
11.8.2 Regulus Therapeutics Business Overview
11.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Introduction
11.8.4 Regulus Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.8.5 Regulus Therapeutics Recent Developments
11.9 Miragen Therapeutics
11.9.1 Miragen Therapeutics Company Details
11.9.2 Miragen Therapeutics Business Overview
11.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Introduction
11.9.4 Miragen Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.9.5 Miragen Therapeutics Recent Developments
11.10 Mina Therapeutics
11.10.1 Mina Therapeutics Company Details
11.10.2 Mina Therapeutics Business Overview
11.10.3 Mina Therapeutics Nucleic Acid-based Drugs Introduction
11.10.4 Mina Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.10.5 Mina Therapeutics Recent Developments
11.11 NeXstar Pharmaceuticals
11.11.1 NeXstar Pharmaceuticals Company Details
11.11.2 NeXstar Pharmaceuticals Business Overview
11.11.3 NeXstar Pharmaceuticals Nucleic Acid-based Drugs Introduction
11.11.4 NeXstar Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2018-2023)
11.11.5 NeXstar Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Nucleic Acid-based Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2023 VS 2033
Table 2. Key Players of ASO
Table 3. Key Players of mRNA
Table 4. Key Players of siRNA
Table 5. Key Players of miRNA
Table 6. Key Players of saRNA
Table 7. Key Players of Aptamer
Table 8. Global Nucleic Acid-based Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2023 VS 2033
Table 9. Global Nucleic Acid-based Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 10. Global Nucleic Acid-based Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Nucleic Acid-based Drugs Market Share by Region (2018-2023)
Table 12. Global Nucleic Acid-based Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Nucleic Acid-based Drugs Market Share by Region (2024-2033)
Table 14. Nucleic Acid-based Drugs Market Trends
Table 15. Nucleic Acid-based Drugs Market Drivers
Table 16. Nucleic Acid-based Drugs Market Challenges
Table 17. Nucleic Acid-based Drugs Market Restraints
Table 18. Global Nucleic Acid-based Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Nucleic Acid-based Drugs Revenue Share by Players (2018-2023)
Table 20. Global Top Nucleic Acid-based Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Drugs as of 2023)
Table 21. Global Nucleic Acid-based Drugs Industry Ranking 2021 VS 2023 VS 2023
Table 22. Global 5 Largest Players Market Share by Nucleic Acid-based Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 23. Global Key Players of Nucleic Acid-based Drugs, Headquarters and Area Served
Table 24. Global Key Players of Nucleic Acid-based Drugs, Product and Application
Table 25. Global Key Players of Nucleic Acid-based Drugs, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nucleic Acid-based Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Nucleic Acid-based Drugs Revenue Market Share by Type (2018-2023)
Table 29. Global Nucleic Acid-based Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Nucleic Acid-based Drugs Revenue Market Share by Type (2024-2033)
Table 31. Global Nucleic Acid-based Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Nucleic Acid-based Drugs Revenue Share by Application (2018-2023)
Table 33. Global Nucleic Acid-based Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Nucleic Acid-based Drugs Revenue Share by Application (2024-2033)
Table 35. North America Nucleic Acid-based Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 36. North America Nucleic Acid-based Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 37. North America Nucleic Acid-based Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 38. North America Nucleic Acid-based Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 39. North America Nucleic Acid-based Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 40. North America Nucleic Acid-based Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Nucleic Acid-based Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Nucleic Acid-based Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 43. Europe Nucleic Acid-based Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 44. Europe Nucleic Acid-based Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 45. Europe Nucleic Acid-based Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 46. Europe Nucleic Acid-based Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 47. Europe Nucleic Acid-based Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Europe Nucleic Acid-based Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 49. China Nucleic Acid-based Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 50. China Nucleic Acid-based Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 51. China Nucleic Acid-based Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 52. China Nucleic Acid-based Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Nucleic Acid-based Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 54. Asia Nucleic Acid-based Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 55. Asia Nucleic Acid-based Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 56. Asia Nucleic Acid-based Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 57. Asia Nucleic Acid-based Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 58. Asia Nucleic Acid-based Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 59. Asia Nucleic Acid-based Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2023 VS 2033
Table 65. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 67. Ionis Pharmaceuticals Company Details
Table 68. Ionis Pharmaceuticals Business Overview
Table 69. Ionis Pharmaceuticals Nucleic Acid-based Drugs Product
Table 70. Ionis Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 71. Ionis Pharmaceuticals Recent Developments
Table 72. Sarepta Therapeutics Company Details
Table 73. Sarepta Therapeutics Business Overview
Table 74. Sarepta Therapeutics Nucleic Acid-based Drugs Product
Table 75. Sarepta Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 76. Sarepta Therapeutics Recent Developments
Table 77. Nippon Shinyaku Company Details
Table 78. Nippon Shinyaku Business Overview
Table 79. Nippon Shinyaku Nucleic Acid-based Drugs Product
Table 80. Nippon Shinyaku Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 81. Nippon Shinyaku Recent Developments
Table 82. BioNTech Company Details
Table 83. BioNTech Business Overview
Table 84. BioNTech Nucleic Acid-based Drugs Product
Table 85. BioNTech Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 86. BioNTech Recent Developments
Table 87. Moderna Therapeutics Company Details
Table 88. Moderna Therapeutics Business Overview
Table 89. Moderna Therapeutics Nucleic Acid-based Drugs Product
Table 90. Moderna Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 91. Moderna Therapeutics Recent Developments
Table 92. CureVac Company Details
Table 93. CureVac Business Overview
Table 94. CureVac Nucleic Acid-based Drugs Product
Table 95. CureVac Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 96. CureVac Recent Developments
Table 97. Alnylam Pharmaceuticals Company Details
Table 98. Alnylam Pharmaceuticals Business Overview
Table 99. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product
Table 100. Alnylam Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 101. Alnylam Pharmaceuticals Recent Developments
Table 102. Regulus Therapeutics Company Details
Table 103. Regulus Therapeutics Business Overview
Table 104. Regulus Therapeutics Nucleic Acid-based Drugs Product
Table 105. Regulus Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 106. Regulus Therapeutics Recent Developments
Table 107. Miragen Therapeutics Company Details
Table 108. Miragen Therapeutics Business Overview
Table 109. Miragen Therapeutics Nucleic Acid-based Drugs Product
Table 110. Miragen Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 111. Miragen Therapeutics Recent Developments
Table 112. Mina Therapeutics Company Details
Table 113. Mina Therapeutics Business Overview
Table 114. Mina Therapeutics Nucleic Acid-based Drugs Product
Table 115. Mina Therapeutics Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 116. Mina Therapeutics Recent Developments
Table 117. NeXstar Pharmaceuticals Company Details
Table 118. NeXstar Pharmaceuticals Business Overview
Table 119. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Product
Table 120. NeXstar Pharmaceuticals Revenue in Nucleic Acid-based Drugs Business (2018-2023) & (US$ Million)
Table 121. NeXstar Pharmaceuticals Recent Developments
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid-based Drugs Market Size Growth Rate by Type, 2018 VS 2023 VS 2033 (US$ Million)
Figure 2. Global Nucleic Acid-based Drugs Market Share by Type: 2023 VS 2033
Figure 3. ASO Features
Figure 4. mRNA Features
Figure 5. siRNA Features
Figure 6. miRNA Features
Figure 7. saRNA Features
Figure 8. Aptamer Features
Figure 9. Global Nucleic Acid-based Drugs Market Size Growth Rate by Application, 2018 VS 2023 VS 2033 (US$ Million)
Figure 10. Global Nucleic Acid-based Drugs Market Share by Application: 2023 VS 2033
Figure 11. Genetic Disease Case Studies
Figure 12. Cancer Case Studies
Figure 13. Cardiovascular Diseases Case Studies
Figure 14. Other Case Studies
Figure 15. Nucleic Acid-based Drugs Report Years Considered
Figure 16. Global Nucleic Acid-based Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Nucleic Acid-based Drugs Market Size, (US$ Million), 2018 VS 2023 VS 2033
Figure 18. Global Nucleic Acid-based Drugs Market Share by Region: 2023 VS 2033
Figure 19. Global Nucleic Acid-based Drugs Market Share by Players in 2023
Figure 20. Global Top Nucleic Acid-based Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid-based Drugs as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Nucleic Acid-based Drugs Revenue in 2023
Figure 22. North America Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Nucleic Acid-based Drugs Market Share by Type (2018-2033)
Figure 24. North America Nucleic Acid-based Drugs Market Share by Application (2018-2033)
Figure 25. North America Nucleic Acid-based Drugs Market Share by Country (2018-2033)
Figure 26. United States Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe Nucleic Acid-based Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 29. Europe Nucleic Acid-based Drugs Market Share by Type (2018-2033)
Figure 30. Europe Nucleic Acid-based Drugs Market Share by Application (2018-2033)
Figure 31. Europe Nucleic Acid-based Drugs Market Share by Country (2018-2033)
Figure 32. Germany Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. China Nucleic Acid-based Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 39. China Nucleic Acid-based Drugs Market Share by Type (2018-2033)
Figure 40. China Nucleic Acid-based Drugs Market Share by Application (2018-2033)
Figure 41. Asia Nucleic Acid-based Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 42. Asia Nucleic Acid-based Drugs Market Share by Type (2018-2033)
Figure 43. Asia Nucleic Acid-based Drugs Market Share by Application (2018-2033)
Figure 44. Asia Nucleic Acid-based Drugs Market Share by Region (2018-2033)
Figure 45. Japan Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. China Taiwan Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. India Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Australia Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Share by Type (2018-2033)
Figure 53. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Share by Application (2018-2033)
Figure 54. Middle East, Africa, and Latin America Nucleic Acid-based Drugs Market Share by Country (2018-2033)
Figure 55. Brazil Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Mexico Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Turkey Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Israel Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GCC Countries Nucleic Acid-based Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Ionis Pharmaceuticals Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 62. Sarepta Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 63. Nippon Shinyaku Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 64. BioNTech Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 65. Moderna Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 66. CureVac Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 67. Alnylam Pharmaceuticals Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 68. Regulus Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 69. Miragen Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 70. Mina Therapeutics Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 71. NeXstar Pharmaceuticals Revenue Growth Rate in Nucleic Acid-based Drugs Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries